Detalhe da pesquisa
1.
A genome-wide association study of contralateral breast cancer in the Women's Environmental Cancer and Radiation Epidemiology Study.
Breast Cancer Res
; 26(1): 16, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263039
2.
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study.
Rheumatology (Oxford)
; 63(1): 93-102, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052534
3.
Cancer risk with tocilizumab/sarilumab, abatacept, and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort study.
Rheumatology (Oxford)
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452297
4.
Long-Term Health Consequences After Ovarian Removal at Benign Hysterectomy : A Nationwide Cohort Study.
Ann Intern Med
; 176(5): 596-604, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068275
5.
Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study.
Breast Cancer Res Treat
; 197(3): 583-591, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482232
6.
Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study.
BMC Med
; 21(1): 225, 2023 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365585
7.
Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.
BMC Med
; 21(1): 418, 2023 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993940
8.
A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
BMC Cancer
; 23(1): 562, 2023 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337133
9.
The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study.
Eur J Epidemiol
; 38(5): 545-557, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988840
10.
Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes.
Breast Cancer Res
; 24(1): 77, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369105
11.
Use of beta-blockers and risk of contralateral breast cancer.
Int J Cancer
; 150(10): 1619-1626, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985760
12.
Pregnancy-associated cancer and the risk of second primary cancer.
Cancer Causes Control
; 33(1): 63-71, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643832
13.
Cancer in pregnancy and the risk of adverse pregnancy and neonatal outcomes: A nationwide cohort study.
BJOG
; 129(9): 1492-1502, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954890
14.
Early life body size, pubertal timing, and risks of benign breast disease in a large cohort of Danish female adolescents and women.
Eur J Pediatr
; 181(8): 3023-3030, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652986
15.
The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study.
Br J Cancer
; 122(7): 1102-1108, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32063603
16.
Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
Breast Cancer Res Treat
; 181(2): 475-485, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328847
17.
Nonaspirin NSAIDs and contralateral breast cancer risk.
Int J Cancer
; 144(6): 1243-1250, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30362513
18.
Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study.
Breast Cancer Res Treat
; 178(1): 199-205, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364000
19.
Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies.
Acta Oncol
; 58(11): 1581-1593, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31393200
20.
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study.
Breast Cancer Res
; 20(1): 149, 2018 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526633